Medical Editor: John P. Cunha, DO, FACOEP
Dianeal PD-2 (peritoneal) Dialysis Solution is used for peritoneal dialysis in patients in acute or chronic renal failure when nondialytic medical therapy is judged to be inadequate. Dianeal PD-2 (peritoneal) Dialysis Solution may also be used to treat certain fluid and electrolyte disturbances, and for patients intoxicated with certain poisons and drugs. Common side effects of Dianeal PD-2 Dialysis Solution include:
- abdominal pain
- infection under the skin around a chronic peritoneal catheter
- catheter blockage
- difficulty in fluid removal
- electrolyte and fluid imbalances
- high or low blood volume
- high or low blood pressure
- disequilibrium syndrome, and
- muscle cramping
Dosing of Dianeal PD-2 is individualized. The mode of therapy (Intermittent Peritoneal Dialysis [IPD], Continuous Ambulatory Peritoneal Dialysis [CAPD], or Continuous Cyclic Peritoneal Dialysis [CCPD]), frequency of treatment, formulation, exchange volume, duration of dwell, and length of dialysis is selected by a physician. Dianeal PD-2 may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Dianeal PD-2 should be administered only if prescribed. Consult your doctor before breastfeeding.
Our Dianeal PD-2 (peritoneal) Dialysis Solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
The following adverse reactions are discussed elsewhere in the label:
Clinical Trials Experience
There are no data available on adverse reactions from controlled clinical trials conducted to evaluate the safety of DIANEAL.
The following adverse experiences have been identified during post-approval use of DIANEAL or in conjunction with performing the peritoneal dialysis procedure. Because these experiences are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship during drug exposure. Most of these adverse experiences are believed to be consequences of peritoneal dialysis.
Infections And Infestations: Fungal peritonitis, Peritonitis bacterial, Catheter related infection
Respiratory, Thoracic, And Mediastinal Disorders: Dyspnea
Gastrointestinal Disorders: Sclerosing encapsulating peritonitis, Peritonitis, Peritoneal cloudy effluent, Vomiting, Diarrhea, Nausea, Constipation, Abdominal pain, Abdominal distension, Abdominal discomfort
Musculoskeletal, Connective Tissue Disorders: Myalgia, Muscle spasms, Musculoskeletal pain
Read the entire FDA prescribing information for Dianeal PD2 (Peritoneal Dialysis Solution)
© Dianeal PD2 Patient Information is supplied by Cerner Multum, Inc. and Dianeal PD2 Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.